Genome-wide CRISPR-Cas9 screens identify mechanisms of BET bromodomain inhibitor sensitivity-Reference-Cited by-同舟云学术

Genome-wide CRISPR-Cas9 screens identify mechanisms of BET bromodomain inhibitor sensitivity

Published:2021-11 Issue:11 Volume:24 Page:103323
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Estoppey David,Schutzius Gabi,Kolter Christian,Salathe Adrian,Wunderlin Tiffany,Meyer Amandine,Nigsch Florian,Bouwmeester Tewis,Hoepfner Dominic^ORCID,Kirkland Susan

Funder

Novartis AG

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference88 articles.

1. Epigenetic and genetic features of 24 colon cancer cell lines;Ahmed;Oncogenesis,2013

2. Lysine acetylation goes global: From epigenetics to metabolism and therapeutics;Ali;Chem. Rev.,2018

3. Bromodomain and extra-terminal motif inhibitors: A review of preclinical and clinical advances in cancer therapy;Alqahtani;Future Sci. OA,2019

4. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: A dose-escalation, open-label, pharmacokinetic, phase 1 study;Amorim;Lancet Haematol.,2016

5. AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: Implications for targeting mTOR during malignancy;Astle;Oncogene,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes;npj Precision Oncology;2024-08-28

2. Small molecule induced STING degradation facilitated by the HECT ligase HERC4;Nature Communications;2024-05-29

3. Heat stress–associated changes in the intestinal barrier, inflammatory signals, and microbiome communities in dairy calves;Journal of Dairy Science;2024-02

4. Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes;2024-01-07

5. ELOA3 : A primate-specific RNA polymerase II elongation factor encoded by a tandem repeat gene cluster;Science Advances;2023-11-24